Justin P Yuan, Lauren R Borchers, Yoonji Lee, Jessica L Buthmann, Saché M Coury, Julian Joachimsthaler, Emma L Jaeger, Tiffany C Ho, Ian H Gotlib
{"title":"The effects of the COVID-19 pandemic on neurobiological functioning in adolescents.","authors":"Justin P Yuan, Lauren R Borchers, Yoonji Lee, Jessica L Buthmann, Saché M Coury, Julian Joachimsthaler, Emma L Jaeger, Tiffany C Ho, Ian H Gotlib","doi":"10.1038/s41398-025-03485-2","DOIUrl":null,"url":null,"abstract":"<p><p>The COVID-19 pandemic and its associated lockdowns were an unprecedented source of stress, with striking adverse effects on adolescents' mental health but relatively unknown effects on important aspects of neurobiological functioning. Using data from 154 adolescents (age M ± SD = 16.2 ± 1.1 years; range = 13.9-19.4) drawn from an ongoing longitudinal study and assessed either before or after the pandemic, we compared the pre-pandemic and post-pandemic groups on three key stress-sensitive biological systems: the hypothalamic-pituitary-adrenal (HPA) axis, immune response, and neural responses to affective stimuli. We found that compared to those assessed before the pandemic, adolescents assessed post-lockdown had significantly lower total cortisol production, elevated levels of systemic inflammation, and reduced neural activation in the prefrontal cortex during affective processing (pseudo-F(1,3250) = 7.43, p = 0.006). These findings suggest that, for adolescents, the experience of the pandemic was associated with significant disruptions in multiple biological systems that are sensitive to stress that might have enduring adverse developmental effects.</p>","PeriodicalId":23278,"journal":{"name":"Translational Psychiatry","volume":"15 1","pages":"276"},"PeriodicalIF":6.2000,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12343994/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41398-025-03485-2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
The COVID-19 pandemic and its associated lockdowns were an unprecedented source of stress, with striking adverse effects on adolescents' mental health but relatively unknown effects on important aspects of neurobiological functioning. Using data from 154 adolescents (age M ± SD = 16.2 ± 1.1 years; range = 13.9-19.4) drawn from an ongoing longitudinal study and assessed either before or after the pandemic, we compared the pre-pandemic and post-pandemic groups on three key stress-sensitive biological systems: the hypothalamic-pituitary-adrenal (HPA) axis, immune response, and neural responses to affective stimuli. We found that compared to those assessed before the pandemic, adolescents assessed post-lockdown had significantly lower total cortisol production, elevated levels of systemic inflammation, and reduced neural activation in the prefrontal cortex during affective processing (pseudo-F(1,3250) = 7.43, p = 0.006). These findings suggest that, for adolescents, the experience of the pandemic was associated with significant disruptions in multiple biological systems that are sensitive to stress that might have enduring adverse developmental effects.
期刊介绍:
Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod''s discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.